Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3188964
Max Phase: Preclinical
Molecular Formula: C19H18F3N3O3S2
Molecular Weight: 343.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3188964
Max Phase: Preclinical
Molecular Formula: C19H18F3N3O3S2
Molecular Weight: 343.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C)C2.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C17H17N3OS2.C2HF3O2/c1-10(21)18-16-15(11-7-8-20(2)9-14(11)23-16)17-19-12-5-3-4-6-13(12)22-17;3-2(4,5)1(6)7/h3-6H,7-9H2,1-2H3,(H,18,21);(H,6,7)
Standard InChI Key: CRVFDTGFVDMVPX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 343.48 | Molecular Weight (Monoisotopic): 343.0813 | AlogP: 3.97 | #Rotatable Bonds: 2 |
Polar Surface Area: 45.23 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.57 | CX Basic pKa: 7.07 | CX LogP: 3.44 | CX LogD: 3.27 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.77 | Np Likeness Score: -2.07 |
1. PubChem BioAssay data set, |
Source(1):